Wells Messersmith, MD, specializes in gastrointestinal (GI) cancers, or cancers of the gut. As the division head of the University of Colorado School of Medicine’s Division of Medical Oncology, Messersmith is pushing the frontiers of anticancer treatments from the intersection of precision medicine and immunotherapy.
Related Articles
News
Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders
June 2, 2022
UCBN
News
Comments Off on Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders
ENGLEWOOD, Colo., June 2, 2022 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and […]
News
Women Get Far More Migraines Than Men – a Neurologist Explains Why, and What Brings Relief
April 29, 2024
UCBN
News, Syndication
Comments Off on Women Get Far More Migraines Than Men – a Neurologist Explains Why, and What Brings Relief
A migraine is far more than just a headache – it’s a debilitating disorder of the nervous system. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Charcoal Toothpaste: Messy Mouthful or Whitening Wonder?
November 17, 2022
UCBN
News
Comments Off on Charcoal Toothpaste: Messy Mouthful or Whitening Wonder?
A fine, black powder emergency room physicians sometimes use for treating patients with overdoses, has entered the health and beauty world in the form of shampoos and soaps to deodorants and toothpaste. Click here to […]
